Výsledky vyhledávání - "Kathy A. Stoakes"

Management of Hypertension in Patients With Diabetes Using an Amlodipine-, Olmesartan Medoxomil-, and Hydrochlorothiazide-Based Titration Regimen

Autor: Richard Sachson, Ali Shojaee, Chunlin Qian, Joel M. Neutel, Thomas Littlejohn, C. Venkata S. Ram, Kathy A. Stoakes

Publikováno v: The American Journal of Cardiology. 107:1346-1352

The safety and efficacy of an amlodipine/olmesartan medoxomil (OM)-based titration regimen was assessed in patients with type 2 diabetes mellitus and hypertension. After a 2- to 3-week placebo run-in period, 207 patients received amlodipine 5 mg and

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fcb73e06c48487314e8aa256ab09670c
https://doi.org/10.1016/j.amjcard.2010.12.045

Zobrazit plný text záznamu

A Randomized, Double-Blind, Forced-Titration Study to Compare Olmesartan Medoxomil versus Losartan Potassium in Patients with Stage 1 and 2 Hypertension

Autor: John M. Flack, Matthew R. Weir, Kathleen J. Chavanu, Robert Dubiel, Wei Li, Kathy A. Stoakes, Henry A. Punzi

Publikováno v: Postgraduate Medicine. 123:80-87

To evaluate the comparative efficacy and safety of once-daily olmesartan medoxomil (OM) and losartan potassium (LOS) in patients with hypertension.This was a multicenter, prospective, randomized, double-blind, active-comparator, forced-titration stud

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b13ea57067f45ee232e01311de5bf9ef
https://doi.org/10.3810/pgm.2011.01.2248

Zobrazit plný text záznamu

Effects of an olmesartan medoxomil based treatment algorithm on 24-hour blood pressure control in patients with hypertension and type 2 diabetes

Autor: Dean J. Kereiakes, Joel M. Neutel, Ali Shojaee, William F. Waverczak, Jianbo Xu, Kathy A. Stoakes

Publikováno v: Current Medical Research and Opinion. 26:721-728

The BENIFICIARY (BENIcar safety and efFICacy evaluatIon: An open-label, single-ARm, titration study in patients with hypertension and tYpe 2 diabetes) study was conducted to evaluate the efficacy and safety of olmesartan medoxomil (OM) plus hydrochlo

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::038e8447fec1cf4bf4598773b8f9a3eb
https://doi.org/10.1185/03007990903553556

Zobrazit plný text záznamu

The Effects of an Olmesartan Medoxomil-Based Treatment Algorithm on 24-Hour Blood Pressure Levels in Elderly Patients Aged 65 and Older

Autor: Ali Shojaee, Joel M. Neutel, Jianbo Xu, Kathy A. Stoakes, Dean J. Kereiakes, Robert Dubiel, William F. Waverczak

Publikováno v: J Clin Hypertens (Greenwich)

This study examined the effect of olmesartan medoxomil (OM) +/- hydrochlorothiazide (HCTZ) on mean 24-hour ambulatory blood pressure, mean seated cuff (Se) blood pressure (BP), and SeBP goal achievement in elderly (65 years and older) patients with h

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c0c32937a358a779273ea62be1747796
https://doi.org/10.1111/j.1751-7176.2009.00147.x

Zobrazit plný text záznamu

Blood pressure-lowering efficacy of an olmesartan medoxomil/hydrochlorothiazide-based treatment algorithm in elderly patients (age ≥65 years) stratified by age, sex and race: subgroup analysis of a 12-week, open-label, single-arm, dose-titration study

Autor: William F. Waverczak, Dean J. Kereiakes, Kathy A. Stoakes, Ali Shojaee, Joel M. Neutel, Jen-Fue Maa

Publikováno v: Drugsaging. 28(6)

Introduction: Hypertension is a leading risk factor for development of heart failure, stroke and renal disease in the elderly. Objective: The objective of this study was to evaluate, by means of a prespecified secondary analysis of a 12-week, open-la

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1d15aeaa0443dd4d2d2229fc74883d6e
https://pubmed.ncbi.nlm.nih.gov/21639407

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání